Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Stock Options (Details)

v3.24.3
Stockholders' Equity - Stock Options (Details) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 09, 2023
Sep. 28, 2024
Mar. 30, 2024
Sep. 30, 2023
Sep. 28, 2024
Sep. 30, 2023
Jun. 29, 2024
Dec. 30, 2023
Nov. 04, 2020
Nov. 03, 2020
Shareholders Equity [Line Items]                    
Common stock issued for consulting agreement (in shares)   0   0            
Options outstanding (in shares)   108,000 114,000   108,000   108,000 114,000    
Stock Options                    
Shareholders Equity [Line Items]                    
Share-based compensation expense   $ 0   $ 1,000 $ 1,500,000 $ 14,000        
Unrecognized compensation expense, net of estimated forfeitures   $ 0     $ 0          
2023 Plan                    
Shareholders Equity [Line Items]                    
Options authorized for issuance (in shares)   2,000,000     2,000,000          
2023 Plan | Restricted Stock Units (RSUs)                    
Shareholders Equity [Line Items]                    
Share-based compensation expense   $ 1,200,000     $ 1,500,000          
Common stock issued for RSU's granted (in shares) 908,852   908,852              
Common stock issued for consulting agreement (in shares)         908,852          
2016 Plan                    
Shareholders Equity [Line Items]                    
Options authorized for issuance (in shares)                 800,000 400,000
Options outstanding (in shares)   100,000     100,000     100,000    
2011 Plan                    
Shareholders Equity [Line Items]                    
Options outstanding (in shares)   8,000     8,000     8,000    
Share-based compensation , number of additional shares authorized (in shares)         0